{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"FDA clears C2N Alzheimer's blood test for symptomatic adults as young as 40","author_name":"techandbusiness.org · Policy","thumbnail_url":"https://assets.newatlas.com/dims4/default/718bc6e/2147483647/strip/true/crop/1354x711+0+93/resize/1200x630!/quality/90/?url=https%3A%2F%2Fnewatlas-brightspot.s3.ap-southeast-2.amazonaws.com%2F2c%2Fef%2Fc3010c0a485b8cf46a519a830d32%2Fscreenshot-2026-08-24-at-10-54-49-am.png&na.image_optimisation=0","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · Policy</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/VCwK_GWoIxiooDd95nvGFC\" style=\"color:#fff;text-decoration:none;\">FDA clears C2N Alzheimer's blood test for symptomatic adults as young as 40</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">The FDA has cleared C2N Diagnostics' PrecivityAD2 blood test for patients as young as 40 who show potential cognitive symptoms of Alzheimer's disease, according to the source. The test measures plasma...</p>\n    </blockquote>"}